No Data
ChemPartner Pharmatech (300149.SZ): As of June 4, the company had 24,470 shareholders.
ChemPartner Pharmatech (300149.SZ) stated on the investor interaction platform on June 6th that as of June 4th, the number of shareholders in the company was 24,470.
Chempartner Pharmatech (300149.SZ) owns a fully integrated R&D and production service platform covering chemical drugs and biologics.
On June 4th, Gelon Hui reported that Chempartner Pharmatech (300149.SZ) has over 20 years of development and accumulation, and has competitive advantages in core technology, innovation ability, customer base, and project experience. 1. The company has a fully integrated research and development and production service platform covering the entire process of chemical medicine and biological medicine, and the service content includes chemical medicine research and development, biological medicine research and development, ADC drug development, biopharmaceutical and pharmacological efficacy, drug metabolism kinetics and early toxicity, and large molecule drug process development and production. Especially for ADC coupling drug one-stop research and development platform, it has been in possession for 15 years.
Meta Bright, ChemPartner Pharmatech to Develop Biotechnology Hub in Malaysia; Shares Rally 6%
Wisdom Pharmaceuticals (300149.SZ): Currently there is no GLP certification
On May 27, Ge Longhui Pharmaceutical (300149.SZ) said on the investor interactive platform that the company currently does not have GLP certification. The company's bioanalysis center can provide bioanalytical services in accordance with FDA/NMPA GLP in pre-clinical and clinical research stages, and has obtained CNAS certification.
Wisdom Pharmaceutical (300149.SZ): Supervisor Qi Jiahui increased her shareholding by 20,000 shares
Gelonghui, May 17, 丨 Wisdom Pharmaceutical (300149.SZ) announced that the company received a “Notice Letter” from the company's supervisor, Ms. Qi Jiahui on May 17, 2024. Based on her confidence in the company's future development and recognition of the company's long-term investment value, she increased her shareholding of 20,000 shares through the Shenzhen Stock Exchange trading system through centralized bidding transactions on May 17, 2024, accounting for 0.0040% of the company's total share capital.
Wisdom Pharmaceutical (300149.SZ): As of May 10, the number of shareholders of the company was 24,987
On May 15, Gelonghui Pharmaceutical (300149.SZ) said on the investor interactive platform that as of May 10, the number of shareholders of the company was 24,987.
Chempartner Pharmatech Co., Ltd.'s (SZSE:300149) Share Price Boosted 31% But Its Business Prospects Need A Lift TooNo Data
